ADS051 / Adiso Therap  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ADS051 / Adiso Therap
NCT05103878: A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects

Completed
1
50
US
BT051 100mg, BT051 300mg, BT051 700mg, BT051 1500mg, BT051 3500mg, Matching Placebo
Bacainn Therapeutics, Inc.
Healthy Volunteers
11/20
11/20
SCOUT, NCT05084261: An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)

Completed
1
24
Europe, US, RoW
BT051 200 mg, ADS051, BT051 800 mg, BT051 3200 mg, Matching Placebo
Adiso Therapeutics
Ulcerative Colitis
11/22
11/22

Download Options